Campbell & Co Investment Adviser’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,036
| Closed | -$489K | – | 1296 |
|
|
2025
Q1 | $489K | Buy |
+22,036
| New | +$489K | 0.04% | 684 |
|
|
2024
Q4 | – | Sell |
-10,550
| Closed | -$264K | – | 1212 |
|
|
2024
Q3 | $264K | Sell |
10,550
-1,960
| -16% | -$49K | 0.02% | 945 |
|
|
2024
Q2 | $234K | Sell |
12,510
-10,047
| -45% | -$188K | 0.02% | 914 |
|
|
2024
Q1 | $445K | Sell |
22,557
-625
| -3% | -$12.3K | 0.04% | 748 |
|
|
2023
Q4 | $407K | Sell |
23,182
-8,713
| -27% | -$153K | 0.04% | 810 |
|
|
2023
Q3 | $554K | Sell |
31,895
-25,379
| -44% | -$441K | 0.07% | 472 |
|
|
2023
Q2 | $806K | Buy |
57,274
+28,032
| +96% | +$395K | 0.14% | 232 |
|
|
2023
Q1 | $315K | Sell |
29,242
-36,288
| -55% | -$390K | 0.06% | 588 |
|
|
2022
Q4 | $982K | Buy |
65,530
+11,686
| +22% | +$175K | 0.23% | 105 |
|
|
2022
Q3 | $691K | Buy |
+53,844
| New | +$691K | 0.16% | 215 |
|